| Title | Value | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Polysaccharide | U-SSPS | ||||||||||||||
| Source Name | Glycine max | ||||||||||||||
| Weight | |||||||||||||||
| Main Glycosidic Bond(s) | |||||||||||||||
| Main Chain | No relevant information could be found in the literature. | ||||||||||||||
| Side Chain | No relevant information could be found in the literature. | ||||||||||||||
| NMR Information | unknown | ||||||||||||||
| Monosaccharide |
|
||||||||||||||
| Physiological Functions | anti-diabetes improve metabolic characteristics and prevent certain diseases, such as diabetes, obesity, cardiovascular disease, etc. | ||||||||||||||
| Intestinal Microbiota Regulation | unknown | ||||||||||||||
| Related Diseases (based on ICD-11) | 5A40-Intermediate hyperglycaemia | ||||||||||||||
| Correlation map | Click to view | ||||||||||||||
| DOI | https://doi.org/10.1016/j.ijbiomac.2020.04.133 |
Data Source Statement:
The data included in the DoLPHiN database is sourced exclusively from peer-reviewed original publications and presented after normalization.
The data included in the DoLPHiN database is sourced exclusively from peer-reviewed original publications and presented after normalization.